Unlock stock picks and a broker-level newsfeed that powers Wall Street.

TSXV - Delayed Quote CAD

LSL Pharma Group Inc. (LSL.V)

Compare
0.3450
-0.0050
(-1.43%)
At close: April 17 at 3:46:51 PM EDT

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. Francois Roberge Chairman, President & CEO 200k -- 1966
Marc Boudreault Vice-President of Communications 138k -- --
Ms. Mélanie St-Pierre CFA Corporate Controller 6.63k -- --
Mr. Luc Mainville M.B.A. CFO & Senior VP -- -- 1964
Francis Chenard Senior VP & COO -- -- --
Mr. Guy Paul Allard Vice President, Legal Affairs & Corporate Secretary -- -- --

LSL Pharma Group Inc.

540, d’Avaugour Street
Suite 1800
Boucherville, QC J4B 0G6
Canada
514 664 7700 https://www.groupelslpharma.com
Sector: 
Healthcare
Full Time Employees: 
114

Description

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. It offers dietary supplements and vitamins in the tablet and capsule form; and niche sterile ophthalmic products in the form of ointments and drops for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.

Corporate Governance

LSL Pharma Group Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers